Earnings Feed
Start Free
Home/Filings/4/0001209191-14-012557
4//SEC Filing

AUXILIUM PHARMACEUTICALS INC 4

Accession 0001209191-14-012557

CIK 0001182129operating
View on SEC.govCompany Profile

Filed

Feb 19, 7:00 PM ET

Accepted

Feb 20, 5:40 PM ET

Size

15.3 KB

Accession

0001209191-14-012557

Insider Transaction Report

Form 4
Period: 2014-02-18
AUXILIUM PHARMACEUTICALS INCAUXL
WILLS ALAN
EVP, Corporate Development
Transactions
  • Award

    Common Stock

    2014-02-18+14,500→ 45,464 total
  • Award

    Restricted Stock Units (Performance Based)

    2014-02-18+24,000→ 24,000 total
    → Common Stock (24,000 underlying)
  • Award

    Common Stock

    2014-02-18+6,375→ 31,668 total
  • Tax Payment

    Common Stock

    2014-02-18$28.30/sh−704$19,923→ 30,964 total
  • Award

    Nonqualified Stock Option (Right to Buy)

    2014-02-18+35,000→ 35,000 total
    Exercise: $28.30From: 2015-02-18Exp: 2024-02-17→ Common Stock (35,000 underlying)
Footnotes (6)
  • [F1]In February 2013, the reporting person was granted a performance share award, with the amount of shares to be determined based on the satisfaction of certain performance criteria. On February 18, 2014, the Compensation Committee awarded 23,775 shares to the reporting person based on its evaluation of the achievement of the performance criteria. These shares vested 33% on February 18, 2014 with the balance vesting in two installments: 33% on February 18, 2015 and 34% on February 18, 2016.
  • [F2]Payment of tax liability by withholding shares incident to the vesting of restricted stock issued in accordance with Rule 16b-3.
  • [F3]The restricted stock units vest in 3 annual installments of 33.33% each beginning on February 18, 2015.
  • [F4]The options vest in 4 equal annual installments beginning on the date indicated in this column.
  • [F5]Each restricted stock unit represents a contingent right to receive, at settlement, one share of stock of Auxilium Pharmaceuticals, Inc. (the "Registrant"). The restricted stock units vest on December 31, 2016.
  • [F6]See Remarks.

Documents

1 file

Issuer

AUXILIUM PHARMACEUTICALS INC

CIK 0001182129

→
Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001182129

Filing Metadata

Form type
4
Filed
Feb 19, 7:00 PM ET
Accepted
Feb 20, 5:40 PM ET
Size
15.3 KB
View on SEC.gov